神経内分泌機能検査の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Neuroendocrine Function Test Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-00802 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、神経内分泌機能検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。神経内分泌機能検査の種類別市場規模（手術、薬）、用途別市場規模（病院、クリニック、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Ipsen、Eli Lilly、Amgen、Roche ・地域別グローバル市場分析 2015年-2020年 ・神経内分泌機能検査の北米市場（アメリカ、カナダ、メキシコ） ・神経内分泌機能検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・神経内分泌機能検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・神経内分泌機能検査の南米市場（ブラジル、アルゼンチン） ・神経内分泌機能検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：手術、薬 ・用途別分析：病院、クリニック、外来手術センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Neuroendocrine Function Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Neuroendocrine Function Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Neuroendocrine Function Test market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Neuroendocrine Function Test market has been segmented into:
Surgery
Medication

By Application, Neuroendocrine Function Test has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuroendocrine Function Test market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuroendocrine Function Test markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuroendocrine Function Test market.

The report offers in-depth assessment of the growth and other aspects of the Neuroendocrine Function Test market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Neuroendocrine Function Test Market Share Analysis
Neuroendocrine Function Test competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuroendocrine Function Test sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuroendocrine Function Test sales, revenue and market share for each player covered in this report.

The major players covered in Neuroendocrine Function Test are:
Novartis
Ipsen
Eli Lilly
Amgen
Roche

レポート目次

---

Table of Contents

1 Neuroendocrine Function Test Market Overview
1.1 Product Overview and Scope of Neuroendocrine Function Test
1.2 Classification of Neuroendocrine Function Test by Type
1.2.1 Global Neuroendocrine Function Test Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Neuroendocrine Function Test Revenue Market Share by Type in 2019
1.2.3 Surgery
1.2.4 Medication
1.3 Global Neuroendocrine Function Test Market by Application
1.3.1 Overview: Global Neuroendocrine Function Test Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Neuroendocrine Function Test Market by Regions
1.4.1 Global Neuroendocrine Function Test Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Neuroendocrine Function Test (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Neuroendocrine Function Test Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Neuroendocrine Function Test Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroendocrine Function Test Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Neuroendocrine Function Test Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroendocrine Function Test Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Neuroendocrine Function Test Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ipsen
2.2.1 Ipsen Details
2.2.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ipsen SWOT Analysis
2.2.4 Ipsen Product and Services
2.2.5 Ipsen Neuroendocrine Function Test Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Neuroendocrine Function Test Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Neuroendocrine Function Test Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Neuroendocrine Function Test Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Neuroendocrine Function Test Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroendocrine Function Test Players Market Share
3.2.2 Top 10 Neuroendocrine Function Test Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Neuroendocrine Function Test Revenue and Market Share by Regions
4.2 North America Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
4.3 Europe Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
4.5 South America Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
5 North America Neuroendocrine Function Test Revenue by Countries
5.1 North America Neuroendocrine Function Test Revenue by Countries (2015-2020)
5.2 USA Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
5.3 Canada Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
5.4 Mexico Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
6 Europe Neuroendocrine Function Test Revenue by Countries
6.1 Europe Neuroendocrine Function Test Revenue by Countries (2015-2020)
6.2 Germany Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
6.3 UK Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
6.4 France Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
6.5 Russia Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
6.6 Italy Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Neuroendocrine Function Test Revenue by Countries
7.1 Asia-Pacific Neuroendocrine Function Test Revenue by Countries (2015-2020)
7.2 China Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
7.3 Japan Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
7.4 Korea Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
7.5 India Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
8 South America Neuroendocrine Function Test Revenue by Countries
8.1 South America Neuroendocrine Function Test Revenue by Countries (2015-2020)
8.2 Brazil Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
8.3 Argentina Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Neuroendocrine Function Test by Countries
9.1 Middle East & Africa Neuroendocrine Function Test Revenue by Countries (2015-2020)
9.2 Saudi Arabia Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
9.3 UAE Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
9.4 Egypt Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
9.5 South Africa Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Neuroendocrine Function Test Revenue and Market Share by Type (2015-2020)
10.2 Global Neuroendocrine Function Test Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2015-2025)
10.4 Medication Revenue Growth Rate (2015-2025)
11 Global Neuroendocrine Function Test Market Segment by Application
11.1 Global Neuroendocrine Function Test Revenue Market Share by Application (2015-2020)
11.2 Neuroendocrine Function Test Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Neuroendocrine Function Test Market Size Forecast (2021-2025)
12.1 Global Neuroendocrine Function Test Market Size Forecast (2021-2025)
12.2 Global Neuroendocrine Function Test Market Forecast by Regions (2021-2025)
12.3 North America Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
12.4 Europe Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
12.6 South America Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Neuroendocrine Function Test Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuroendocrine Function Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuroendocrine Function Test Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Neuroendocrine Function Test Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Neuroendocrine Function Test Major Business
Table 7. Novartis Neuroendocrine Function Test Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Neuroendocrine Function Test Product and Solutions
Table 10. Novartis Neuroendocrine Function Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Ipsen Corporate Information, Location and Competitors
Table 12. Ipsen Neuroendocrine Function Test Major Business
Table 13. Ipsen Neuroendocrine Function Test Total Revenue (USD Million) (2018-2019)
Table 14. Ipsen SWOT Analysis
Table 15. Ipsen Neuroendocrine Function Test Product and Solutions
Table 16. Ipsen Neuroendocrine Function Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eli Lilly Corporate Information, Location and Competitors
Table 18. Eli Lilly Neuroendocrine Function Test Major Business
Table 19. Eli Lilly Neuroendocrine Function Test Total Revenue (USD Million) (2017-2018)
Table 20. Eli Lilly SWOT Analysis
Table 21. Eli Lilly Neuroendocrine Function Test Product and Solutions
Table 22. Eli Lilly Neuroendocrine Function Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Amgen Corporate Information, Location and Competitors
Table 24. Amgen Neuroendocrine Function Test Major Business
Table 25. Amgen Neuroendocrine Function Test Total Revenue (USD Million) (2017-2018)
Table 26. Amgen SWOT Analysis
Table 27. Amgen Neuroendocrine Function Test Product and Solutions
Table 28. Amgen Neuroendocrine Function Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Roche Corporate Information, Location and Competitors
Table 30. Roche Neuroendocrine Function Test Major Business
Table 31. Roche Neuroendocrine Function Test Total Revenue (USD Million) (2017-2018)
Table 32. Roche SWOT Analysis
Table 33. Roche Neuroendocrine Function Test Product and Solutions
Table 34. Roche Neuroendocrine Function Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Neuroendocrine Function Test Revenue (Million USD) by Players (2015-2020)
Table 36. Global Neuroendocrine Function Test Revenue Share by Players (2015-2020)
Table 37. Global Neuroendocrine Function Test Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Neuroendocrine Function Test Revenue Market Share by Regions (2015-2020)
Table 39. North America Neuroendocrine Function Test Revenue by Countries (2015-2020)
Table 40. North America Neuroendocrine Function Test Revenue Market Share by Countries (2015-2020)
Table 41. Europe Neuroendocrine Function Test Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Neuroendocrine Function Test Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Neuroendocrine Function Test Revenue by Countries (2015-2020)
Table 44. South America Neuroendocrine Function Test Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Neuroendocrine Function Test Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Neuroendocrine Function Test Revenue Market Share by Countries (2015-2020)
Table 47. Global Neuroendocrine Function Test Revenue (Million USD) by Type (2015-2020)
Table 48. Global Neuroendocrine Function Test Revenue Share by Type (2015-2020)
Table 49. Global Neuroendocrine Function Test Revenue Forecast by Type (2021-2025)
Table 50. Global Neuroendocrine Function Test Revenue by Application (2015-2020)
Table 51. Global Neuroendocrine Function Test Revenue Share by Application (2015-2020)
Table 52. Global Neuroendocrine Function Test Revenue Forecast by Application (2021-2025)
Table 53. Global Neuroendocrine Function Test Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Neuroendocrine Function Test Picture
Figure 2. Global Neuroendocrine Function Test Revenue Market Share by Type in 2019
Figure 3. Surgery Picture
Figure 4. Medication Picture
Figure 5. Neuroendocrine Function Test Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Global Neuroendocrine Function Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Neuroendocrine Function Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Neuroendocrine Function Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Neuroendocrine Function Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Neuroendocrine Function Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Neuroendocrine Function Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Neuroendocrine Function Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Neuroendocrine Function Test Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Neuroendocrine Function Test Revenue Market Share in 2019
Figure 18. Global Top 10 Players Neuroendocrine Function Test Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Neuroendocrine Function Test Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Neuroendocrine Function Test Revenue Market Share by Regions (2015-2020)
Figure 22. Global Neuroendocrine Function Test Revenue Market Share by Regions in 2018
Figure 23. North America Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 24. Europe Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 26. South America Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 28. North America Neuroendocrine Function Test Revenue Market Share by Countries (2015-2020)
Figure 29. North America Neuroendocrine Function Test Revenue Market Share by Countries in 2019
Figure 30. USA Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 31. Canada Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 33. Europe Neuroendocrine Function Test Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Neuroendocrine Function Test Revenue Market Share by Countries in 2019
Figure 35. Germany Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 36. UK Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 37. France Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 38. Russia Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 39. Italy Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Neuroendocrine Function Test Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Neuroendocrine Function Test Revenue Market Share by Countries in 2019
Figure 42. China Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 43. Japan Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 44. Korea Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 45. India Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 47. South America Neuroendocrine Function Test Revenue Market Share by Countries (2015-2020)
Figure 48. South America Neuroendocrine Function Test Revenue Market Share by Countries in 2019
Figure 49. Brazil Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Neuroendocrine Function Test Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Neuroendocrine Function Test Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 54. UAE Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Neuroendocrine Function Test Revenue and Growth Rate (2015-2020)
Figure 57. Global Neuroendocrine Function Test Revenue Share by Type (2015-2020)
Figure 58. Global Neuroendocrine Function Test Revenue Share by Type in 2019
Figure 59. Global Neuroendocrine Function Test Market Share Forecast by Type (2021-2025)
Figure 60. Global Surgery Revenue Growth Rate (2015-2020)
Figure 61. Global Medication Revenue Growth Rate (2015-2020)
Figure 62. Global Neuroendocrine Function Test Revenue Share by Application (2015-2020)
Figure 63. Global Neuroendocrine Function Test Revenue Share by Application in 2019
Figure 64. Global Neuroendocrine Function Test Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 68. Global Neuroendocrine Function Test Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Neuroendocrine Function Test Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Neuroendocrine Function Test Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
Figure 72. Europe Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
Figure 74. South America Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Neuroendocrine Function Test Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---